SCHEMBL22239268

SCHEMBL22239268

CCCC(C)CCCCCCNCC

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.48
CYP2C19 P33261 2/20 0.48
CYP1A2 P05177 1/20 0.48
KDM1A O60341 5/20 0.45
MEN1 O00255 1/20 0.44
GLA P06280 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 1/20 0.39
ACE2 Q9BYF1 1/20 0.38
LMNA P02545 1/20 0.37
ADH1B P00325 2/20 0.35
ADH1C P00326 2/20 0.35
ADH1A P07327 2/20 0.35
ADH4 P08319 2/20 0.35
ADH7 P40394 2/20 0.35
SAT1 P21673 2/20 0.34
HRH4 Q9H3N8 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
EPHX1 P07099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19731211 1.00 TSHR (0.48) TSHRCYP2C19CYP1A2KDM1AMEN1
SCHEMBL13339807 0.98 TSHR (0.50) TSHRCYP2C19CYP1A2KDM1AMEN1
SCHEMBL14175670 0.91 TSHR (0.54) TSHRCYP2C19CYP1A2KDM1AMEN1
SCHEMBL7031486 0.91 TSHR (0.52) TSHRCYP2C19CYP1A2KDM1AMEN1
SCHEMBL21165536 0.89 TSHR (0.54) TSHRCYP2C19CYP1A2KDM1AMEN1
SCHEMBL20756195 0.89 TSHR (0.56) TSHRCYP2C19CYP1A2KDM1AMEN1
SCHEMBL20387836 0.87 TSHR (0.44) TSHRCYP2C19CYP1A2MEN1GLA
SCHEMBL11507752 0.86 CYP2C19 (0.52) TSHRCYP2C19CYP1A2KDM1AMEN1
SCHEMBL20841975 0.85 LMNA (0.58) TSHRCYP2C19CYP1A2KDM1AMEN1
SCHEMBL19882782 0.85 LMNA (0.52) TSHRCYP2C19CYP1A2MEN1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020214537-A1 MODULATORS OF RAS GTPASE TOSK, INC. (US) 2020-10-22 WO disclosed
EP-3683207-A1 N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOSTERIC MODULATORS OF NR2B Cadent Therapeutics, Inc. (US) 2020-07-22 EP disclosed